Close
Almac
Achema middle east

Yuvraj

Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC

Progenics Pharmaceuticals, Inc.reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate (ADC) designed to selectively deliver chemotherapy...

CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing

CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT and Stemina have entered into a strategic partnership. Under...

New potential drug targets discovered for preventing prostate cancer cell growth

Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition...

Rodent models meeting need for reduced drug attrition rates

What are the strategies for reducing drug attrition rates in the clinic through the application of transgenic rodent models?‘Fail early, fail often’. It’s a...

Personalized medicine: The partnership imperative

Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of...

Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated

Cumberland Pharmaceuticals Inc.announced the publication of data from a clinical trial evaluating the pharmacokinetics, safety and tolerability of a rapid infusion of Caldolor® (ibuprofen)...

Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines

Eli Lilly and Company announced that the Mirror Portfolio, a concept created by Lilly to access innovation being developed outside the company's walls, has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »